Alogliptin benzoate
|
|
|
- CAS-Nr.
- 850649-62-6
- Englisch Name:
- Alogliptin benzoate
- Synonyma:
- Nesina;CS-247;SYR 322;Aglitin API;Alogliptin API;NESINA; SYR 322;benjisuanageliedin;Alogiptin Benzoate;Aggliptin benzoate;ALOGLIPTIN BENZOATE
- CBNumber:
- CB61011067
- Summenformel:
- C25H27N5O4
- Molgewicht:
- 461.52
- MOL-Datei:
- 850649-62-6.mol
|
Alogliptin benzoate Eigenschaften
- Schmelzpunkt:
- 180-182°C
- storage temp.
- Refrigerator, under inert atmosphere
- L?slichkeit
- Chloroform (Slightly, Heated), DMSO (Slightly, Heated), Methanol (Slightly, Heat
- Aggregatzustand
- Solid
- Farbe
- White to Off-White
- InChIKey
- KEJICOXJTRHYAK-AVAJOTNLNA-N
- SMILES
- C(C1C=CC=CC=1)(=O)O.C(C1C=CC=CC=1C#N)N1C(N(C)C(=O)C=C1N1CCC[C@@H](N)C1)=O |&1:30,r|
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Alogliptin benzoate Chemische Eigenschaften,Einsatz,Produktion Methoden
Definition
ChEBI: A benzoate salt obtained by combining equimolar amounts of alogliptin and benzoic acid. Used for treatment of type 2 diabetes.
Clinical Use
Alogliptin benzoate is a dipeptidyl peptidase IV (DPPIV) inhibitor discovered by Takeda
Pharmaceuticals and approved in Japan in 2010 for the treatment of type II diabetes mellitus.
Alogliptin is an oral drug for once a day dosing to complement diet and exercise. Alogliptin is the most
selective marketed DPPIV inhibition and has similar PK and PD properties compared to previous entries. The discovery, structure-activity relationship of related analogs, and synthesis of this
compound have been recently published.
Alogliptin benzoate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Alogliptin benzoate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 511)Lieferanten
850649-62-6()Verwandte Suche:
- (R)-2-((6-(3-aMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile benzoate
- Alogliptin benzoate 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile benzoate
- Alogliptin(Alogliptin benzoate
- 2-[6-[3(R)-AMinopiperidin-1-yl]-3-Methyl-2,4-dioxo-1,2,3,4-tetrahydropyriMidin-1-ylMethyl]benzonitrile benzoate Monobenzoate
- Alogliptin API
- ALOGLIPTIN(SYK-322) BENZOATE
- (R)-2-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benz
- 2-[[6-[(3R)-3-aMino-1-piperidinyl]-3,4-dihydro-3-Methyl-2,4-dioxo-1(2H)-pyriMidinyl]Methyl]-Benzonitrile Monobenzoate
- SYR 322
- 2-[6-[3(R)-AMinopiperidin-1-yl]-3-Methyl-2,4-dioxo-1,2,3,4-tetrahydropyriMidin-1-ylMethyl]benzonitrile benzoate
- ALOGLIPTIN BENZOATE
- 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile benzoate
- API-Reducing Blood Sugar
- Alogliptin (benzoate salt)
- Hot sale top quality Alogliptin Benzoate with factory price
- Alogliptin Benzoate CAS: 850649-62-6
- Alogliptin benzoate(SYR 322)
- Benzoic acid, Glenn
- NESINA; SYR 322
- 2-[6-benzonitrile benzoate
- benjisuanageliedin
- CS-247
- Alogiptin Benzoate
- Aglitin API
- Alogliptin（SYR-322）benzoate
- Alogliptin benzoate ISO 9001：2015 REACH
- Agleretine Benzoate Impurity
- 2-[6-[3(R)-Aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-t...
- Nesina
- 2(1H)-Pyridinone,5,6-dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-7-piperidinyl)phenyl]-
- Estr-4-en-3-one,17-hydroxy-,(23β)-
- Aggliptin benzoate
- 2-[[6-[(3R)-3-amino-1-piperidyl]-3-methyl-2,4-dioxo-pyrimidin-1-yl]methyl]benzonitrile
- 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile benzoate (1:1)
- Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-, monobenzoate
- Avagliptin benzoate
- 850649-62-6
- 850649-60-6
- 850649-62-5
- C18H21N5O2C7H6O2
- antidiabetic
- Inhibitors
- pharmaceutical intermediate
- Final material
- API
- 850649-62-6
